This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Teva Pharmaceutical 4.50% 2025-03 EUR

Update! New bond issue: Teva Pharmaceutical (NYSE:TEVA) issued new debt notes (XS1789456024) (144A: XS1789459473) for 900M EUR as of March 7, 2018. Tradable at Euronext Dublin as of April 5, 2018. New tranche for 900M EUR with issue date April 19, 2018. Listed at Stuttgart Stock Exchange as of June 5, 2018.

Teva Pharmaceutical Finance NV operates in the Netherlands as a finance subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company.

IssuerTeva Pharmaceutical Finance
Stock (Group)NYSE:TEVA
Bond TypeCorporate
CategorySenior, Callable
Maturity DateMarch 1, 2025
Residual Duration4 years, 2 months, 26 days
CurrencyEUR (Euro)
Coupon TypeFixed Rate
Coupon (Yearly)4.500%
Coupon FrequencySemiannual
Minimum Lot100,000 EUR
Additional Lots1,000 EUR
Issue DateMarch 14, 2018
Issued Amount900,000,000 EUR
Tranche Amount900,000,000 EUR
Issue Price100.000%
Maturity Price100.000%
Home ExchangeDublin
Other ExchangesFrankfurt, Berlin, Stuttgart, Munich
IsinXS1789456024
Isin 144AXS1789459473 (144A)
Temporary IsinXS1813724603 XS1808319245 (exchange)
Issue DocumentationIssue Prospectus
IndustryPharmaceuticals
SectorHealth Care
CountryNetherlands
RegionEurope developed


Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, EUR, Fixed Rate, Income


Next Jewel UK 8.50% 2023-04 GBP

investopoli.com